Lebrikizumab Found Effective for Patients With AD, SOC
SAN DIEGO — Among patients with skin of color and moderate to severe atopic dermatitis (AD) who underwent 16 weeks ...
Read moreDetails
Tag: Lebrikizumab
How Does Lebrikizumab Perform Across Different Subgroups?
Lebrikizumab, an investigational interleukin-13 inhibitor, showed significant efficacy compared with placebo across racial and ethnic subgroups in patients with moderate-to-severe ...
Read moreDetails
The Earth News is an independent English-language daily published Website from all around the World News
